FATE THERAPEUTICS INC (FATE) Stock Balance Sheet
NASDAQ:FATE - Nasdaq - US31189P1021 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 37.91M | 41.87M | 61.30M | 133.60M | 167.30M | |||
| Marketable Securities | 259.01M | 273.31M | 374.90M | 482.30M | 315.60M | |||
| Receivables | 4.13M | 1.83M | 38.50M | 8.70M | 5.50M | |||
| Other Current Assets | 9.24M | 14.54M | 27.40M | 8.80M | 5.90M | |||
| Total Current Assets | 310.29M | 331.54M | 502.10M | 633.40M | 494.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 140.83M | 158.51M | 176.10M | 162.20M | 99.40M | |||
| Investments And Advances | 33.61M | 980.00K | 4.90M | 100.70M | N/A | |||
| Other Non-Current Assets | 10.24M | 15.19M | 15.30M | 15.30M | 15.20M | |||
| Total Non-Current Assets | 184.68M | 174.68M | 203.50M | 288.10M | 128.20M | |||
| TOTAL ASSETS | 494.97M | 506.22M | 705.60M | 921.50M | 622.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 30.47M | 33.69M | 59.60M | 48.00M | 18.90M | |||
| Accounts Payable | 6.35M | 4.72M | 8.30M | 8.60M | 6.30M | |||
| Other Current Liabilities | 600.00K | 685.00K | 46.20M | 24.70M | 60.40M | |||
| Total Current Liabilities | 37.42M | 39.09M | 114.10M | 81.30M | 85.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 95.22M | 98.71M | 107.60M | 161.30M | 152.40M | |||
| Total Non-Current Liabilities | 95.22M | 98.71M | 107.50M | 161.30M | 152.40M | |||
| TOTAL LIABILITIES | 132.64M | 137.80M | 221.60M | 242.60M | 238.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.35B | -1.21B | -1.05B | -769.10M | -556.90M | |||
| Additional Paid In Capital | 1.71B | 1.58B | 1.54B | 1.45B | 941.20M | |||
| Common Shares | 117.00K | 102.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 835.00K | 15.00K | -1.90M | -800.00K | 100.00K | |||
| Shares Outstanding | 113.88M | 98.63M | 97.30M | 95.70M | 87.70M | |||
| Tangible Book Value per Share | 3.18 | 3.74 | 4.97 | 7.09 | 4.38 | |||
| Total Shareholders' Equity | 362.33M | 368.42M | 483.90M | 678.80M | 384.40M | |||
| TOTAL LIABILITIES AND EQUITY | 494.97M | 506.22M | 705.60M | 921.50M | 622.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 8.29 | 8.48 | 4.40 | 7.79 | 5.77 | |||
| Return On Assets (ROA) | -36.01% | -31.79% | -39.93% | -23.02% | -27.85% | |||
| Return On Equity (ROE) | -49.19% | -43.68% | -58.22% | -31.25% | -45.11% | |||
All data in USD , ROIC based on taxRate of 0.21